Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -14,175 | -8,879 | -3,668 | N/A |
| Depreciation Amortization | N/A | 275 | 176 | 86 | N/A |
| Accounts payable and accrued liabilities | N/A | 292 | 372 | 128 | N/A |
| Other Working Capital | N/A | 493 | 1,824 | 382 | N/A |
| Other Operating Activity | 0 | 3,323 | 769 | 346 | 0 |
| Operating Cash Flow | $N/A | $-9,792 | $-5,738 | $-2,726 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -654 | -559 | -274 | N/A |
| Purchase Sale Intangibles | N/A | -76 | -61 | -28 | N/A |
| Other Investing Activity | 0 | -76 | -61 | -28 | 0 |
| Investing Cash Flow | $N/A | $-730 | $-620 | $-302 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 80,610 | 366 | 5 | N/A |
| Other Financing Activity | 0 | -1,268 | -310 | 47 | 0 |
| Financing Cash Flow | $N/A | $79,342 | $56 | $52 | $N/A |
| Beginning Cash Position | N/A | 17,539 | 17,539 | 17,539 | N/A |
| End Cash Position | N/A | 86,359 | 11,237 | 14,563 | N/A |
| Net Cash Flow | $N/A | $68,820 | $-6,302 | $-2,976 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -9,792 | -5,738 | -2,726 | N/A |
| Capital Expenditure | N/A | -654 | -559 | -274 | N/A |
| Free Cash Flow | 0 | -10,446 | -6,297 | -3,000 | 0 |